You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies.
|
|---|---|
| Published in |
Cancer Immunology Research, September 2022
|
| DOI | 10.1158/2326-6066.cir-21-0722 |
| Pubmed ID | |
| Authors |
Filip Janku, Sae-Won Han, Toshihiko Doi, Alessio Amatu, Jaffer A Ajani, Yasutoshi Kuboki, Alex Cortez, Susan E Cellitti, Ping C Mahling, Kulandayan Subramanian, Heidi A Schoenfeld, Sarah M Choi, Lori A Iaconis, Lang Ho Lee, Marc R Pelletier, Glenn Dranoff, Vasileios Askoxylakis, Salvatore Siena |
X Demographics
The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 34% |
| Italy | 1 | 3% |
| Brazil | 1 | 3% |
| Switzerland | 1 | 3% |
| Czechia | 1 | 3% |
| Germany | 1 | 3% |
| Unknown | 14 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 52% |
| Practitioners (doctors, other healthcare professionals) | 8 | 28% |
| Scientists | 6 | 21% |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 22 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 23% |
| Professor | 3 | 14% |
| Unspecified | 2 | 9% |
| Student > Ph. D. Student | 2 | 9% |
| Other | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 8 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 5 | 23% |
| Engineering | 3 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 9% |
| Unspecified | 2 | 9% |
| Chemistry | 2 | 9% |
| Other | 1 | 5% |
| Unknown | 7 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 59. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2022.
All research outputs
#731,443
of 25,658,139 outputs
Outputs from Cancer Immunology Research
#67
of 1,584 outputs
Outputs of similar age
#17,286
of 436,428 outputs
Outputs of similar age from Cancer Immunology Research
#5
of 35 outputs
Altmetric has tracked 25,658,139 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,584 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,428 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.